CP
Covenant Partners Portfolio holdings
AUM
$335M
This Quarter Return
+6.32%
1 Year Return
+16.95%
3 Year Return
+65.96%
5 Year Return
+111.98%
10 Year Return
–
AUM
$265M
AUM Growth
+$265M
(+5.5%)
Cap. Flow
+$1.48M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
49.35%
Holding
208
New
7
Increased
13
Reduced
28
Closed
7
Top Buys
| 1 |
Canadian Pacific Kansas City
CP
|
$1.39M |
| 2 |
iShares MSCI EAFE Value ETF
EFV
|
$910K |
| 3 |
Unilever
UL
|
$377K |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
$371K |
| 5 |
DexCom
DXCM
|
$358K |
Top Sells
| 1 |
Takeda Pharmaceutical
TAK
|
$482K |
| 2 |
SPLK
Splunk Inc
SPLK
|
$357K |
| 3 |
Verizon
VZ
|
$310K |
| 4 |
Novartis
NVS
|
$299K |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$231K |
Sector Composition
| 1 | Technology | 17.39% |
| 2 | Healthcare | 8.06% |
| 3 | Financials | 7.83% |
| 4 | Consumer Discretionary | 6.21% |
| 5 | Industrials | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
iShares Russell 2000 ETF
IWM
$67B
| $20K | 0.01% |
89
| – | – |
|
|
202
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – |
-3,054
| Closed | -$231K |
|
203
BorgWarner
BWA
$9.25B
| – | – |
-4,601
| Closed | -$213K |
|
204
Neurocrine Biosciences
NBIX
$13.8B
| – | – |
-2,055
| Closed | -$200K |
|
205
Reinsurance Group of America
RGA
$12.9B
| – | – |
-1,674
| Closed | -$211K |
|
206
Saia
SAIA
$7.9B
| – | – |
-876
| Closed | -$202K |
|
207
Sun Communities
SUI
$15.9B
| – | – |
-1,526
| Closed | -$229K |
|
208
WEC Energy
WEC
$34.3B
| – | – |
-2,389
| Closed | -$224K |
|